2Mancia G,De Backer G,Dominiczak A,et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension [ J ]. J Hypertens, 2007,25; 1751-1762.
3Kim KI,Chang HJ,Cho YS,et al. Current status and characteris- tics of hypertension control in community resident elderly korean people:data from a korean longitudinal study on health and ag- ing ( KLoSHa study ) [ J ]. Hypertension Res, 2005,31 : 97 - 105.
4Stratton IM,Cull CA,Adler AI,et al. Additive effects of gly- caemia and blood pressure exposure on risk of complications in type 2 diabetes :a prospective observational study [J]. Diabetolo- gia, 2006,49 : 1761 - 1769.
5Heim A,Feihl F,Waeber B. ADVANCE:a morbidity mortality study of diabetes and hypertension [ J ]. Rev Med Suisse, 2008,4 : 28,30,32-33.
6Beckett NS,Peters R,Fletcher AE,et al. Treatment of hyperten- son in Ptients 80 years of age or older [J]. N Engl J Med, 2008,358 : 1887-1898.
7He J, Gu D, Chen J, et al. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet, 2009, 374 : 1765-1772.
8Wald DS, Law M, Mmxis JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med, 2009, 122 : 290-300.
9ACCORD Study Group, Cushman WC, Evans GW, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med, 2010, 362 : 1575-1585.
10Akerstrom F, Rodrtguez-Padial L. Hypertension, the J-Curve and the INVEST Trial. Am J Cardiol, 2011, 107: 490-491.
10Jeemon P,Stephen 1VL Health outcomes in Indians in comparison with other countries: India specific summary findings based on World Health Statistics(2008)[J]. Indian J Med Res,2009,130(5) :570-571.
